Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Wave Life Sciences (WVE) Shares Outstanding (Weighted Average) (2016 - 2025)

Historic Shares Outstanding (Weighted Average) for Wave Life Sciences (WVE) over the last 11 years, with Q3 2025 value amounting to $167.7 million.

  • Wave Life Sciences' Shares Outstanding (Weighted Average) rose 2653.5% to $167.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $167.7 million, marking a year-over-year increase of 2653.5%. This contributed to the annual value of $138.3 million for FY2024, which is 3033.08% up from last year.
  • Wave Life Sciences' Shares Outstanding (Weighted Average) amounted to $167.7 million in Q3 2025, which was up 2653.5% from $164.0 million recorded in Q2 2025.
  • Wave Life Sciences' Shares Outstanding (Weighted Average)'s 5-year high stood at $167.7 million during Q3 2025, with a 5-year trough of $49.1 million in Q1 2021.
  • Moreover, its 5-year median value for Shares Outstanding (Weighted Average) was $103.8 million (2023), whereas its average is $102.2 million.
  • As far as peak fluctuations go, Wave Life Sciences' Shares Outstanding (Weighted Average) skyrocketed by 8517.2% in 2022, and later skyrocketed by 2281.82% in 2024.
  • Wave Life Sciences' Shares Outstanding (Weighted Average) (Quarter) stood at $51.8 million in 2021, then surged by 52.16% to $78.9 million in 2022, then skyrocketed by 34.55% to $106.1 million in 2023, then soared by 30.33% to $138.3 million in 2024, then increased by 21.31% to $167.7 million in 2025.
  • Its Shares Outstanding (Weighted Average) stands at $167.7 million for Q3 2025, versus $164.0 million for Q2 2025 and $162.5 million for Q1 2025.